Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration enables selective binding to specific enzyme active sites, enhancing drug efficacy and reducing off-target effects. Commonly employed in the production of investigational oncology compounds where stereochemistry plays a critical role in biological activity. Also utilized in the preparation of serotonin and dopamine receptor modulators for central nervous system disorders. Its hydrochloride salt form improves stability and solubility, facilitating formulation in aqueous-based dosage forms.